Cargando…
ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer
In a previous study, we found that ERGIC3 was a novel lung cancer-related gene by screening libraries of differentially expressed genes. In this study, we developed a new murine monoclonal antibody (mAb) against ERGIC3. This avid antibody (6-C4) is well suited for immunohistochemistry, immunoblottin...
Autores principales: | Lin, Qing-Hai, Zhang, Kui-Dong, Duan, He-Xian, Liu, Min-Xia, Wei, Wan-Li, Cao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638005/ https://www.ncbi.nlm.nih.gov/pubmed/26177443 http://dx.doi.org/10.1111/cas.12741 |
Ejemplares similares
-
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017) -
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011) -
Mechanism of epithelial-mesenchymal transition inhibited by miR-203 in non-small cell lung cancer
por: Huang, Weicong, et al.
Publicado: (2020) -
The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015) -
Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)